Patents by Inventor Andrew Dunham

Andrew Dunham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESSING TRANSACTIONS INVOLVING CARD READER DEVICES CONTAINERIZED EXECUTION OF CODE
    Publication number: 20240061927
    Abstract: A method and apparatus for executing code in a container are described. In one embodiment, the method comprises generating code on a host computer system using a user interface; and executing the code inside a container on the host computer system, including performing access control based on one or more properties of the host computer system.
    Type: Application
    Filed: November 3, 2023
    Publication date: February 22, 2024
    Inventors: Karla Burnett, Andrew Reitz, Yasha Mostofi-Ashtiani, Jason Shantz, Justin Sippel, Andrew Dunham, Shawn Moore, Adam Zev Sorkin
  • Processing transactions involving card reader devices containerized execution of code
    Patent number: 11822642
    Abstract: A method and apparatus for executing code in a container are described. In one embodiment, the method comprises generating code on a host computer system using a user interface; and executing the code inside a container on the host computer system, including performing access control based on one or more properties of the host computer system.
    Type: Grant
    Filed: October 29, 2020
    Date of Patent: November 21, 2023
    Assignee: STRIPE, INC.
    Inventors: Karla Burnett, Andrew Reitz, Yasha Mostofi-Ashtiani, Jason Shantz, Justin Sippel, Andrew Dunham, Shawn Moore, Adam Zev Sorkin
  • Methods for Managing Adverse Events in Patients with Inflammation
    Publication number: 20230248767
    Abstract: Methods for prevention and reversal of inflammation.
    Type: Application
    Filed: January 20, 2023
    Publication date: August 10, 2023
    Applicant: Hemanext Inc.
    Inventors: Andrew DUNHAM, Tatsuro YOSHIDA, Samuel O. SOWEMIMO-COKER
  • Methods and Treatment of Trauma
    Publication number: 20230165896
    Abstract: Methods for the reversal of hemorrhagic shock or hemorrhagic trauma.
    Type: Application
    Filed: January 9, 2023
    Publication date: June 1, 2023
    Applicant: Hemanext Inc.
    Inventors: Andrew DUNHAM, Tatsuro YOSHIDA
  • Methods for Managing Adverse Events in Patient Populations Requiring Transfusion
    Publication number: 20230047634
    Abstract: Method for transfusion medicine to reduce adverse events in transfusion patient populations based on underlying patient physiology.
    Type: Application
    Filed: October 28, 2022
    Publication date: February 16, 2023
    Applicant: Hemanext Inc.
    Inventors: Angelo D'ALESSANDRO, Rafael CORDERO, Andrew DUNHAM, Philip KEEGAN, Tatsuro YOSHIDA
  • Methods and treatment of trauma adverse events with oxygen reduced blood
    Patent number: 11576931
    Abstract: Methods for the reversal of hemorrhagic shock or hemorrhagic trauma. Methods for restoring mean arterial pressure to a normal range and reducing trauma adverse risks in a patient through the administration of oxygen reduced blood compositions.
    Type: Grant
    Filed: June 4, 2021
    Date of Patent: February 14, 2023
    Assignee: Hemanext Inc.
    Inventors: Andrew Dunham, Tatsuro Yoshida
  • Methods for the Preservation of Reagent Red Blood Cells Using Carbon Monoxide
    Publication number: 20220330541
    Abstract: This application provides methods, compositions, and kits for use blood group determination and the preparation of improved red blood cell containing reagents for use in blood typing of blood prior to its use in transfusion medicine.
    Type: Application
    Filed: September 4, 2020
    Publication date: October 20, 2022
    Applicant: Hemanext Inc.
    Inventors: Tatsuro YOSHIDA, Andrew Dunham
  • PROCESSING TRANSACTIONS INVOLVING CARD READER DEVICES CONTAINERIZED EXECUTION OF CODE
    Publication number: 20220138312
    Abstract: A method and apparatus for executing code in a container are described. In one embodiment, the method comprises generating code on a host computer system using a user interface; and executing the code inside a container on the host computer system, including performing access control based on one or more properties of the host computer system.
    Type: Application
    Filed: October 29, 2020
    Publication date: May 5, 2022
    Inventors: Karla Burnett, Andrew Reitz, Yasha Mostofi-Ashtiani, Jason Shantz, Justin Sippel, Andrew Dunham, Shawn Moore, Adam Zev Sorkin
  • METHODS AND TREATMENT OF TRAUMA ADVERSE EVENTS WITH OXYGEN REDUCED BLOOD
    Publication number: 20220118008
    Abstract: Methods for the reversal of hemorrhagic shock or hemorrhagic trauma. Methods for restoring mean arterial pressure to a normal range and reducing trauma adverse risks in a patient through the administration of oxygen reduced blood compositions.
    Type: Application
    Filed: June 4, 2021
    Publication date: April 21, 2022
    Applicant: Hemanext Inc.
    Inventors: Andrew DUNHAM, Tatsuro YOSHIDA
  • METHODS FOR MANAGING ADVERSE EVENTS IN PATIENTS WITH INFLAMMATION
    Publication number: 20210401883
    Abstract: Methods for prevention and reversal of inflammation.
    Type: Application
    Filed: November 14, 2019
    Publication date: December 30, 2021
    Applicant: Hemanext Inc.
    Inventors: Andrew DUNHAM, Tatsuro YOSHIDA, Samuel O. SOWEMIMO-COKER
  • METHODS AND TREATMENT OF TRAUMA ADVERSE EVENTS WITH OXYGEN REDUCED BLOOD
    Publication number: 20210290669
    Abstract: Methods for the reversal of hemorrhagic shock or hemorrhagic trauma. Methods for restoring mean arterial pressure to a normal range and reducing trauma adverse risks in a patient through the administration of oxygen reduced blood compositions.
    Type: Application
    Filed: June 4, 2021
    Publication date: September 23, 2021
    Applicant: Hemanext Inc.
    Inventors: Andrew DUNHAM, Tatsuro YOSHIDA
  • Methods and treatment for reducing the risk of an inflammatory response
    Patent number: 11090331
    Abstract: Method for transfusion medicine to reduce adverse events in transfusion patient populations based on underlying patient physiology. Methods for reducing the risk of an inflammatory response in a sickle cell patient in need of a blood transfusion.
    Type: Grant
    Filed: May 15, 2020
    Date of Patent: August 17, 2021
    Assignee: Hemanext Inc.
    Inventors: Angelo D'Alessandro, Rafael Cordero, Andrew Dunham, Philip Keegan, Tatsuro Yoshida
  • Methods and treatment of trauma adverse events with oxygen reduced blood
    Patent number: 11052110
    Abstract: Methods for the reversal of hemorrhagic shock or hemorrhagic trauma. Methods for restoring mean arterial pressure to a normal range and reducing trauma adverse risks in a patient through the administration of oxygen reduced blood compositions.
    Type: Grant
    Filed: August 14, 2020
    Date of Patent: July 6, 2021
    Assignee: Hemanext Inc.
    Inventors: Andrew Dunham, Tatsuro Yoshida
  • Methods and treatment of trauma adverse events with oxygen reduced blood
    Patent number: 11033581
    Abstract: Methods for the reversal of hemorrhagic shock or hemorrhagic trauma. Methods for restoring mean arterial pressure to a normal range and reducing trauma adverse risks in a patient through the administration of oxygen reduced blood compositions.
    Type: Grant
    Filed: April 15, 2020
    Date of Patent: June 15, 2021
    Assignee: Hemanext Inc.
    Inventors: Andrew Dunham, Tatsuro Yoshida
  • Methods and treatment of trauma adverse events with oxygen reduced blood
    Patent number: 11026971
    Abstract: Methods for the reversal of hemorrhagic shock or hemorrhagic trauma. Methods for restoring mean arterial pressure to a normal range and reducing trauma adverse risks in a patient through the administration of oxygen reduced blood compositions.
    Type: Grant
    Filed: June 16, 2020
    Date of Patent: June 8, 2021
    Assignee: Hemanext Inc.
    Inventors: Andrew Dunham, Tatsuro Yoshida
  • Methods and treatment of trauma adverse events with oxygen reduced blood
    Patent number: 11026970
    Abstract: Methods for the reversal of hemorrhagic shock or hemorrhagic trauma. Methods for restoring mean arterial pressure to a normal range and reducing trauma adverse risks in a patient through the administration of oxygen reduced blood compositions.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: June 8, 2021
    Assignee: Hemanext Inc.
    Inventors: Andrew Dunham, Tatsuro Yoshida
  • METHODS AND TREATMENT OF TRAUMA
    Publication number: 20210030790
    Abstract: Methods for the reversal of hemorrhagic shock or hemorrhagic trauma.
    Type: Application
    Filed: August 14, 2020
    Publication date: February 4, 2021
    Applicant: Hemanext Inc.
    Inventors: Andrew DUNHAM, Tatsuro YOSHIDA
  • Methods and treatment of trauma adverse events with oxygen reduced blood
    Patent number: 10898517
    Abstract: Methods for the reversal of hemorrhagic shock or hemorrhagic trauma. Methods for restoring mean arterial pressure to a normal range and reducing trauma adverse risks in a patient through the administration of oxygen reduced blood compositions.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: January 26, 2021
    Assignee: Hemanext Inc.
    Inventors: Andrew Dunham, Tatsuro Yoshida
  • METHODS AND TREATMENT OF TRAUMA
    Publication number: 20200376027
    Abstract: Methods for the reversal of hemorrhagic shock or hemorrhagic trauma.
    Type: Application
    Filed: June 16, 2020
    Publication date: December 3, 2020
    Applicant: Hemanext Inc.
    Inventors: Andrew DUNHAM, Tatsuro YOSHIDA
  • METHODS FOR MANAGING ADVERSE EVENTS IN PATIENT POPULATIONS REQUIRING TRANSFUSION
    Publication number: 20200276234
    Abstract: Method for transfusion medicine to reduce adverse events in transfusion patient populations based on underlying patient physiology.
    Type: Application
    Filed: May 15, 2020
    Publication date: September 3, 2020
    Applicant: Hemanext Inc.
    Inventors: Angelo D'Alessandro, Rafael Cordero, Andrew Dunham, Philip Keegan, Tatsuro Yoshida